EUVIMEDEUVIMED entdecken
Crossref

Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India

Abu Bashar, Sanket V Nandekar, Prerna Shrivastava, Ravi Nandini Singh, Pushkar Srikrishnan

Journal of Vector Borne Diseases · 2023

DOI: 10.4103/0972-9062.374034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vector Borne Diseases, 2023. Verfasst von Abu Bashar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community and Family Medicine, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Elephantiasis, Filarial, Filaricides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives: Lymphatic filariasis is targeted for elimination in India through mass drug administration (MDA) with diethylcarbamazine (DEC) combined with albendazole (ABZ). To assess the coverage, compliance and causes for non-compliance towards MDA in an endemic district of Uttar Pradesh (U.P.), north India.

Methods

A cross-sectional coverage evaluation survey was conducted in 24 rural and 6 urban clusters of Ghazipur district in eastern U.P. using multi-stage random sampling technique with probability proportional to estimated size (PPES). Data was collected in a semi-structured Performa from all the individuals in the selected households by interview technique. Bivariate analysis was performed to identify the factors associated with non-consumption of MDA drugs.

Results

A total of 1422 individuals were surveyed from 30 randomly selected subunits of which 1401 (98.5%) were eligible for MDA at the time of the round. Majority of the participants were in the age-group of 15–59 years (67.0%) and were males (53.3%). The overall coverage of MDA (both drugs) among the eligible population in Ghazipur district was 58.5%. Compliance among those who had received both the drugs was 61.6% with effective coverage of 36.0%. The coverage was significantly higher in rural areas compared to the urban clusters (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Elephantiasis, FilarialFilaricidesMaleHumansAdolescentYoung AdultAdultMiddle AgedFemaleMass Drug AdministrationCross-Sectional StudiesDiethylcarbamazineAlbendazoleIndia

Stichwörter der Autor:innen

ComplianceCoverageEndemicFilariasis elimination programmeMass-drug-administration

Substanzen

FilaricidesDiethylcarbamazineAlbendazole

Autor:innen und Institutionen

  • Department of Community and Family Medicine, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
  • Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

Zitieren

APA

Bashar, A., Nandekar, S. V., Shrivastava, P., Singh, R. N., & Srikrishnan, P. (2023). Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India. Journal of Vector Borne Diseases. https://doi.org/10.4103/0972-9062.374034

Vancouver

Bashar A, Nandekar SV, Shrivastava P, Singh RN, Srikrishnan P. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India. Journal of Vector Borne Diseases. 2023. doi:10.4103/0972-9062.374034

BibTeX
@article{Bashar2023,
  author = {Bashar, Abu and Nandekar, Sanket V and Shrivastava, Prerna and Singh, Ravi Nandini and Srikrishnan, Pushkar},
  title = {Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India},
  journal = {Journal of Vector Borne Diseases},
  year = {2023},
  doi = {10.4103/0972-9062.374034}
}
Kostenlos starten →